AI-Native Primary Market Research for Life Sciences

A 200-respondent study in days, not months.

Sentari runs Primary Market Research studies end-to-end with AI agent moderators — recruiting, interviewing and synthesizing across HCPs and patients in parallel. The same study your panel vendor would deliver in three months, returned in three days at a fraction of the cost.

200 interviews per study3-day insight deliveryUp to 85% lower cost vs. traditional panels
The Sentari Engine

A complete PMR study, drafted before lunch.

Today, Sentari runs Primary Market Research studies end-to-end — agent moderators recruit, interview and synthesize while your team reviews the work as it lands. Market intelligence and real-world evidence join the engine next, on the same architecture.

Tier 1 · Agent LayerIngestion & Synthesis

Primary Market Research

Synthetic + human-in-loop interviews
Live

Agent moderators run 200 structured interviews with HCPs and patients in parallel, surfacing themes and quantified findings in 3 days versus a traditional 3 months.

Market Intelligence

Competitive & market access signals
28 signals · 4h

Tracks regulatory approvals, label changes, payer activity and KOL signals across global markets — agents triage and corroborate before anything reaches your inbox.

Claims & Real-World Evidence

Anonymized EHR / claims streams
Streaming

1.2M longitudinal patient records continuously cohort-matched against your indication, with 94.7% match precision and audit-grade lineage on every series.

Tier 2 · Output LayerArtifacts · Action · Simulations
Artifacts

Generated work products

PDFSales Battlecard · Segment CReady
PPTBrand Dossier · Product XPending
XLSPayer Dossier · EU7Ready
Agentic Action

Always-on sentinels

● Opportunity
+12% sentiment shift · Tier 1 cardiologists
Deploy Marketing Segment →
● Field Optimization
Reallocate District X → District Y
Simulate impact →
Simulations

Scenario modeling

$1.06B · Y4
3 trajectoriesPayer · Adherence · Comp.
Insight delivery
3 days
vs. 3 months traditional — 30× faster cycle time.
Agent interviews
200 /study
HCPs and patients, in parallel, with audited transcripts.
Cost per study
−85%
Versus a traditional panel-vendor program of comparable scope.
Refresh cadence
Weekly
Re-run the same study against fresh respondents — no new SOW.
Capabilities

PMR studies, reimagined.

Everything your panel vendor does — recruiting, moderating, transcribing, synthesizing, reporting — run by agents under your team's review, in days instead of months.

Agent-moderated interviews

Run 200 structured interviews with HCPs and patients in parallel. Agents probe, follow up and re-ask the way a senior moderator would — every transcript reviewable by your team.

Quantified synthesis

Themes surface with sample-weighted percentages and quoted evidence, every claim hyperlinked to the transcript timestamp it came from.

Study-ready deliverables

Topline reports, segmentation decks and verbatim libraries drafted in your template — ready for your team to review, edit and present.

Studies we run

Built for the studies where you need results in days, not months.

Concept tests, message validation, segmentation, patient journey research — every PMR study type your team runs, returned in the same week the brief is filed.

Launch readiness research, on the launch team's timeline.

Pre-launch HCP & patient PMR delivered in days, not months. Agent moderators interview your full target panel in parallel while your team reviews findings as they land.

  • 200 interviews with HCPs & patients across your target segments — in parallel
  • Quantified themes with quoted evidence, citation-linked to transcripts
  • Topline report + verbatim library in your template, ready for review
Study ProgressLive
Interviews complete156 / 200
Themes identified12 themes
Transcripts reviewed97 / 156
Report draftedIn progress
Latest theme
"Dosing frequency was the primary barrier cited by 67% of HCPs in the cardiology segment."
Transcript #142 · 4 min ago
Questions, answered

What teams ask before they sign.

How does Sentari replace traditional market research vendors?+

Sentari isn't a single-shot study tool — it's an always-on engine. The same workflow that delivers your initial brief continues running: refreshing the panel weekly, surfacing new signals, and re-drafting affected artifacts automatically. Your in-house team owns the engine; legacy vendors get consolidated.

Where does the data come from, and is it patient-identifiable?+

Claims and EHR streams come from contracted partners with full data-use agreements, and arrive de-identified at the boundary. Primary research transcripts are stored encrypted with PHI redaction applied before any model touches them. Regional residency is enforced for EU and APAC tenants.

What does the human review workflow look like?+

Every artifact moves through your configured review gates — medical, legal, regulatory, brand — with one-click annotations linked to the source evidence. You decide which sentinels can act autonomously and which must propose. Nothing leaves the engine without an audit trail.

How long does implementation actually take?+

Most pilots are live within 72 hours of contract signing — the engine is multi-tenant by default. Full template configuration (brand voice, dossier formats, review gates, integrations) typically lands in week two, run by our launch engineers alongside your team.

Which therapeutic areas do you cover today?+

Sentari is generalist by design — agent moderators and signal taxonomies are reconfigured per indication. Deepest current libraries are in oncology, cardiometabolic, immunology and rare disease, with new TAs added in roughly two-week cycles.

Ready to compress your timeline?

See the full engine with your own brief. A 30-minute working session with our launch engineers — no slides, no sales theater.

3-day study delivery200 interviews per studyNo rip-and-replace required